Equities research analysts at StockNews.com assumed coverage on shares of SenesTech (NASDAQ:SNES – Get Free Report) in a research report issued on Wednesday. The brokerage set a “sell” rating on the stock.
Separately, HC Wainwright raised their target price on shares of SenesTech from $3.50 to $10.00 and gave the company a “buy” rating in a research note on Thursday, December 12th.
Read Our Latest Report on SNES
SenesTech Stock Performance
SenesTech Company Profile
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Further Reading
- Five stocks we like better than SenesTech
- Stock Splits, Do They Really Impact Investors?
- Rocket Lab’s Growth Strategy: Small Rockets, Massive Potential
- The 3 Best Blue-Chip Stocks to Buy Now
- Goldman Sachs vs. Morgan Stanley—Which Stock Has More Upside?
- 3 Best Fintech Stocks for a Portfolio Boost
- 3 Reasons Bulls Will Win on Super Micro Computer Stock
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.